메뉴 건너뛰기




Volumn 122, Issue 7, 2013, Pages 1192-1202

The JAK-inhibitor ruxolitinib impairs dendritic cell function in vitro and in vivo

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CD69 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; GLYCOPROTEIN P 15095; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA DR ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 12; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; OVALBUMIN; RUXOLITINIB; T6 ANTIGEN; CYTOKINE; JANUS KINASE; PYRAZOLE DERIVATIVE;

EID: 84887193830     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-03-484642     Document Type: Article
Times cited : (292)

References (36)
  • 1
    • 0034720161 scopus 로고    scopus 로고
    • Myelofibrosis with myeloid metaplasia
    • Tefferi A. Myelofibrosis with myeloid metaplasia. N Engl J Med. 2000;342(17):1255-1265.
    • (2000) N Engl J Med. , vol.342 , Issue.17 , pp. 1255-1265
    • Tefferi, A.1
  • 2
    • 30344484239 scopus 로고    scopus 로고
    • The v617f jak2 mutation and the myeloproliferative disorders
    • Percy MJ, McMullin MF. The V617F JAK2 mutation and the myeloproliferative disorders. Hematol Oncol. 2005;23(3-4):91-93.
    • (2005) Hematol Oncol , vol.23 , Issue.3-4 , pp. 91-93
    • Percy, M.J.1    McMullin, M.F.2
  • 3
    • 34548240698 scopus 로고    scopus 로고
    • Role of jak2 in the pathogenesis and therapy of myeloproliferative disorders
    • Levine RL, Pardanani A, Tefferi A, Gilliland DG. Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders. Nat Rev Cancer. 2007;7(9):673-683.
    • (2007) Nat Rev Cancer , vol.7 , Issue.9 , pp. 673-683
    • Levine, R.L.1    Pardanani, A.2    Tefferi, A.3    Gilliland, D.G.4
  • 4
    • 77950684805 scopus 로고    scopus 로고
    • Preclinical characterization of the selective Jak1/2 inhibitor incb018424: Therapeutic implications for the treatment of myeloproliferative neoplasms
    • Quintás-Cardama A, Vaddi K, Liu P, et al. Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms. Blood. 2010;115(15):3109-3117.
    • (2010) Blood , vol.115 , Issue.15 , pp. 3109-3117
    • Quintás-Cardama, A.1    Vaddi, K.2    Liu, P.3
  • 5
    • 84857837774 scopus 로고    scopus 로고
    • Jak inhibition with ruxolitinib versus best available therapy for myelofibrosis
    • Harrison C, Kiladjian JJ, Al-Ali HK, et al. JAK inhibition with ruxolitinib versus best available therapy for myelofibrosis. N Engl J Med. 2012; 366(9):787-798.
    • (2012) N Engl J Med , vol.366 , Issue.9 , pp. 787-798
    • Harrison, C.1    Kiladjian, J.J.2    Al-Ali, H.K.3
  • 6
    • 84872260963 scopus 로고    scopus 로고
    • Jak2 inhibitors for myelofibrosis: Why are they effective in patients with and without jak2v617f mutation?
    • Santos FP, Verstovsek S. JAK2 inhibitors for myelofibrosis: why are they effective in patients with and without JAK2V617F mutation? Anticancer Agents Med Chem. 2012;12(9): 1098-1109.
    • (2012) Anticancer Agents Med Chem , vol.12 , Issue.9 , pp. 1098-1109
    • Santos, F.P.1    Verstovsek, S.2
  • 9
    • 34547108380 scopus 로고    scopus 로고
    • Jak-stat signaling: From interferons to cytokines
    • Schindler C, Levy DE, Decker T. JAK-STAT signaling: from interferons to cytokines. J Biol Chem. 2007;282(28):20059-20063.
    • (2007) J Biol Chem. , vol.282 , Issue.28 , pp. 20059-20063
    • Schindler, C.1    Levy, D.E.2    Decker, T.3
  • 10
    • 77949759544 scopus 로고    scopus 로고
    • Loss of jak2 selectively suppresses dc-mediated innate immune response and protects mice from lethal dose of lps-induced septic shock
    • Zhong J, Yang P, Muta K, et al. Loss of Jak2 selectively suppresses DC-mediated innate immune response and protects mice from lethal dose of LPS-induced septic shock. PLoS ONE. 2010;5(3):e9593.
    • (2010) Plos ONE , vol.5 , Issue.3
    • Zhong, J.1    Yang, P.2    Muta, K.3
  • 11
    • 78049422716 scopus 로고    scopus 로고
    • Ifn-g activated jak1 shifts cd40-induced cytokine profiles in human antigen-presenting cells toward high il-12p70 and low il-10 production
    • Conzelmann M, Wagner AH, Hildebrandt A, et al. IFN-g activated JAK1 shifts CD40-induced cytokine profiles in human antigen-presenting cells toward high IL-12p70 and low IL-10 production. Biochem Pharmacol. 2010;80(12): 2074-2086.
    • (2010) Biochem Pharmacol , vol.80 , Issue.12 , pp. 2074-2086
    • Conzelmann, M.1    Wagner, A.H.2    Hildebrandt, A.3
  • 12
    • 48149088642 scopus 로고    scopus 로고
    • Generation of antigen-specific ctl responses using rgs1 mrna transfected dendritic cells
    • Grünebach F, Erndt S, Häntschel M, Heine A, Brossart P. Generation of antigen-specific CTL responses using RGS1 mRNA transfected dendritic cells. Cancer Immunol Immunother. 2008;57(10):1483-1491.
    • (2008) Cancer Immunol Immunother , vol.57 , Issue.10 , pp. 1483-1491
    • Grünebach, F.1    Erndt, S.2    Häntschel, M.3    Heine, A.4    Brossart, P.5
  • 13
    • 79953677184 scopus 로고    scopus 로고
    • Regulation of dectin-1-mediated dendritic cell activation by peroxisome proliferator-activated receptor-gamma ligand troglitazone
    • Kock G, Bringmann A, Held SA, Daecke S, Heine A, Brossart P. Regulation of dectin-1-mediated dendritic cell activation by peroxisome proliferator-activated receptor-gamma ligand troglitazone. Blood. 2011;117(13):3569-3574.
    • (2011) Blood , vol.117 , Issue.13 , pp. 3569-3574
    • Kock, G.1    Bringmann, A.2    Held, S.A.3    Daecke, S.4    Heine, A.5    Brossart, P.6
  • 14
    • 0026481133 scopus 로고
    • Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/ macrophage colony-stimulating factor
    • Inaba K, Inaba M, Romani N, et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/ macrophage colony-stimulating factor. J Exp Med. 1992;176(6):1693-1702.
    • (1992) J Exp Med. , vol.176 , Issue.6 , pp. 1693-1702
    • Inaba, K.1    Inaba, M.2    Romani, N.3
  • 15
    • 0033012030 scopus 로고    scopus 로고
    • An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow
    • Lutz MB, Kukutsch N, Ogilvie AL, et al. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods. 1999; 223(1):77-92.
    • (1999) J Immunol Methods , vol.223 , Issue.1 , pp. 77-92
    • Lutz, M.B.1    Kukutsch, N.2    Ogilvie, A.L.3
  • 16
    • 77949830320 scopus 로고    scopus 로고
    • Alternative cross-priming through ccl17-ccr4-mediated attraction of ctls toward nkt cell-licensed dcs
    • Semmling V, Lukacs-Kornek V, Thaiss CA, et al. Alternative cross-priming through CCL17-CCR4-mediated attraction of CTLs toward NKT cell-licensed DCs. Nat Immunol. 2010;11(4):313-320.
    • (2010) Nat Immunol , vol.11 , Issue.4 , pp. 313-320
    • Semmling, V.1    Lukacs-Kornek, V.2    Thaiss, C.A.3
  • 17
    • 28444455582 scopus 로고    scopus 로고
    • Ppar-gamma agonists inhibit toll-like receptor-mediated activation of dendritic cells via the map kinase and nf-kappab pathways
    • Appel S, Mirakaj V, Bringmann A, Weck MM, Grünebach F, Brossart P. PPAR-gamma agonists inhibit toll-like receptor-mediated activation of dendritic cells via the MAP kinase and NF-kappaB pathways. Blood. 2005;106(12):3888-3894.
    • (2005) Blood , vol.106 , Issue.12 , pp. 3888-3894
    • Appel, S.1    Mirakaj, V.2    Bringmann, A.3    Weck, M.M.4    Grünebach, F.5    Brossart, P.6
  • 18
    • 33947383077 scopus 로고    scopus 로고
    • Zoledronic acid inhibits the function of toll-like receptor 4 ligand activated monocyte-derived dendritic cells
    • Bringmann A, Schmidt SM, Weck MM, et al. Zoledronic acid inhibits the function of Toll-like receptor 4 ligand activated monocyte-derived dendritic cells. Leukemia. 2007;21(4):732-738.
    • (2007) Leukemia , vol.21 , Issue.4 , pp. 732-738
    • Bringmann, A.1    Schmidt, S.M.2    Weck, M.M.3
  • 19
    • 63449141174 scopus 로고    scopus 로고
    • Proteasome inhibition overcomes the resistance of renal cell carcinoma cells against the ppargamma ligand troglitazone
    • von Schwarzenberg K, Held SA, Schaub A, Brauer KM, Bringmann A, Brossart P. Proteasome inhibition overcomes the resistance of renal cell carcinoma cells against the PPARgamma ligand troglitazone. Cell Mol Life Sci. 2009;66(7):1295-1308.
    • (2009) Cell Mol Life Sci , vol.66 , Issue.7 , pp. 1295-1308
    • Von Schwarzenberg, K.1    Held, S.A.2    Schaub, A.3    Brauer, K.M.4    Bringmann, A.5    Brossart, P.6
  • 20
    • 84877820487 scopus 로고    scopus 로고
    • Imatinib mesylate and nilotinib affect mhc-class i presentation by modulating the proteasomal processing of antigenic peptides
    • Held SA, Duchardt KM, Tenzer S, et al. Imatinib mesylate and nilotinib affect MHC-class I presentation by modulating the proteasomal processing of antigenic peptides. Cancer Immunol Immunother. 2013;62(4):715-726.
    • (2013) Cancer Immunol Immunother , vol.62 , Issue.4 , pp. 715-726
    • Held, S.A.1    Duchardt, K.M.2    Tenzer, S.3
  • 21
    • 0031055468 scopus 로고    scopus 로고
    • Construction of adenovirus vectors through cre-lox recombination
    • Hardy S, Kitamura M, Harris-Stansil T, Dai Y, Phipps ML. Construction of adenovirus vectors through Cre-lox recombination. J Virol. 1997; 71(3):1842-1849.
    • (1997) J Virol , vol.71 , Issue.3 , pp. 1842-1849
    • Hardy, S.1    Kitamura, M.2    Harris-Stansil, T.3    Dai, Y.4    Phipps, M.L.5
  • 22
    • 0035033218 scopus 로고    scopus 로고
    • Transfer of hepatitis b virus genome by adenovirus vectors into cultured cells and mice: Crossing the species barrier
    • Sprinzl MF, Oberwinkler H, Schaller H, Protzer U. Transfer of hepatitis B virus genome by adenovirus vectors into cultured cells and mice: crossing the species barrier. J Virol. 2001;75(11): 5108-5118.
    • (2001) J Virol , vol.75 , Issue.11 , pp. 5108-5118
    • Sprinzl, M.F.1    Oberwinkler, H.2    Schaller, H.3    Protzer, U.4
  • 23
    • 77950606986 scopus 로고    scopus 로고
    • Bioluminescence imaging allows measuring cd8 t cell function in the liver
    • Stabenow D, Frings M, Trück C, et al. Bioluminescence imaging allows measuring CD8 T cell function in the liver. Hepatology. 2010; 51(4):1430-1437.
    • (2010) Hepatology , vol.51 , Issue.4 , pp. 1430-1437
    • Stabenow, D.1    Frings, M.2    Trück, C.3
  • 24
    • 0033151538 scopus 로고    scopus 로고
    • Secondary lymphoid-tissue chemokine (slc) is chemotactic for mature dendritic cells
    • Chan VW, Kothakota S, Rohan MC, et al. Secondary lymphoid-tissue chemokine (SLC) is chemotactic for mature dendritic cells. Blood. 1999;93(11):3610-3616.
    • (1999) Blood , vol.93 , Issue.11 , pp. 3610-3616
    • Chan, V.W.1    Kothakota, S.2    Rohan, M.C.3
  • 25
    • 84864716411 scopus 로고    scopus 로고
    • Placebo-controlled trial of tofacitinib monotherapy in rheumatoid arthritis
    • Fleischmann R, Kremer J, Cush J, et al; ORAL Solo Investigators. Placebo-controlled trial of tofacitinib monotherapy in rheumatoid arthritis. N Engl J Med. 2012;367(6):495-507.
    • (2012) N Engl J Med. , vol.367 , Issue.6 , pp. 495-507
    • Fleischmann, R.1    Kremer, J.2    Cush, J.3
  • 26
    • 0028289244 scopus 로고
    • Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha
    • Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med. 1994;179(4):1109-1118.
    • (1994) J Exp Med. , vol.179 , Issue.4 , pp. 1109-1118
    • Sallusto, F.1    Lanzavecchia, A.2
  • 27
  • 28
    • 77949529017 scopus 로고    scopus 로고
    • Granzyme b produced by human plasmacytoid dendritic cells suppresses t-cell expansion
    • Jahrsdörfer B, Vollmer A, Blackwell SE, et al. Granzyme B produced by human plasmacytoid dendritic cells suppresses T-cell expansion. Blood. 2010;115(6):1156-1165.
    • (2010) Blood , vol.115 , Issue.6 , pp. 1156-1165
    • Jahrsdörfer, B.1    Vollmer, A.2    Blackwell, S.E.3
  • 30
    • 84870325487 scopus 로고    scopus 로고
    • Regulation of inflammatory responses in tumor necrosis factor-activated and rheumatoid arthritis synovial macrophages by jak inhibitors
    • Yarilina A, Xu K, Chan C, Ivashkiv LB. Regulation of inflammatory responses in tumor necrosis factor-activated and rheumatoid arthritis synovial macrophages by JAK inhibitors. Arthritis Rheum. 2012;64(12):3856-3866.
    • (2012) Arthritis Rheum , vol.64 , Issue.12 , pp. 3856-3866
    • Yarilina, A.1    Xu, K.2    Chan, C.3    Ivashkiv, L.B.4
  • 31
    • 84857239335 scopus 로고    scopus 로고
    • The jak inhibitor cp-690,550 (tofacitinib) inhibits tnf-induced chemokine expression in fibroblast-like synoviocytes: Autocrine role of type i interferon
    • Rosengren S, Corr M, Firestein GS, Boyle DL. The JAK inhibitor CP-690,550 (tofacitinib) inhibits TNF-induced chemokine expression in fibroblast-like synoviocytes: autocrine role of type I interferon. Ann Rheum Dis. 2012;71(3): 440-447.
    • (2012) Ann Rheum Dis , vol.71 , Issue.3 , pp. 440-447
    • Rosengren, S.1    Corr, M.2    Firestein, G.S.3    Boyle, D.L.4
  • 32
    • 80053437858 scopus 로고    scopus 로고
    • Janus kinase/signal transducer and activator of transcription 3 signaling pathway is crucial in chemokine production from hepatocytes infected by dengue virus
    • Tsai YT, Chen YH, Chang DM, Chen PC, Lai JH. Janus kinase/signal transducer and activator of transcription 3 signaling pathway is crucial in chemokine production from hepatocytes infected by dengue virus. Exp Biol Med (Maywood). 2011; 236(10):1156-1165.
    • (2011) Exp Biol Med (maywood) , vol.236 , Issue.10 , pp. 1156-1165
    • Tsai, Y.T.1    Chen, Y.H.2    Chang, D.M.3    Chen, P.C.4    Lai, J.H.5
  • 33
    • 84877618100 scopus 로고    scopus 로고
    • An opportunistic infection associated with ruxolitinib, a novel janus kinase 1,2 inhibitor
    • Wysham NG, Sullivan DR, Allada G. An opportunistic infection associated with ruxolitinib, a novel janus kinase 1,2 inhibitor. Chest. 2013; 143(5):1478-1479.
    • (2013) Chest , vol.143 , Issue.5 , pp. 1478-1479
    • Wysham, N.G.1    Sullivan, D.R.2    Allada, G.3
  • 34
  • 35
    • 84864066214 scopus 로고    scopus 로고
    • Preliminary clinical activity of a topical Jak1/2 inhibitor in the treatment of psoriasis
    • Punwani N, Scherle P, Flores R, et al. Preliminary clinical activity of a topical JAK1/2 inhibitor in the treatment of psoriasis. J Am Acad Dermatol. 2012;67(4):658-664.
    • (2012) J Am Acad Dermatol , vol.67 , Issue.4 , pp. 658-664
    • Punwani, N.1    Scherle, P.2    Flores, R.3
  • 36
    • 80051788025 scopus 로고    scopus 로고
    • Preclinical evaluation of local jak1 and jak2 inhibition in cutaneous inflammation
    • Fridman JS, Scherle PA, Collins R, et al. Preclinical evaluation of local JAK1 and JAK2 inhibition in cutaneous inflammation. J Invest Dermatol. 2011;131(9):1838-1844.
    • (2011) J Invest Dermatol. , vol.131 , Issue.9 , pp. 1838-1844
    • Fridman, J.S.1    Scherle, P.A.2    Collins, R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.